ACE2 |
Angiotensin converting enzyme 2 |
CD4+T cells |
Cluster of differentiation 4 T helper cells |
CXCL 9, 10, 11 |
Chemokines 9, 10, 11 |
DFT |
Density functional theory |
FADD |
Fas-associated protein with death domain |
GPX4 |
Glutathione peroxidase 4 |
HSP 60, 70,90 |
Heat shock protein 60, 70,90 |
IL |
Interleukin |
iNOS |
Inducible nitric oxide synthase |
IRF |
Interferon |
JAK1 |
Janus Kinase 1 |
LAP |
LC3-associated phagocytosis |
MHCI |
major histocompatibility complex |
MLKL |
Mixed lineage kinase domain like pseudokinase |
MMP-9 |
Matrix metallopeptidase 9 |
NF-κB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
NK-cells |
Natural killer cells |
NO |
Nitric oxide |
NRF2 |
Nuclear factor erythroid-derived 2-like 2 |
P53 |
Tumor protein P53 |
PARP |
Poly (ADP-ribose) polymerase |
PI3K/AKT/mTOR pathway |
Phosphatidylinositol 3-kinases/lpha serine/threonine-protein kinase/mammalian target of rapamycin |
ROS |
Reactive oxygen species |
Se |
Selenium |
Sec |
Selenocysteine |
SELENO |
Selenoprotein |
STAT1 |
Signal transducer and activator of transcription 1 |
TLR2,4 |
Toll-like receptor 2,4 |
TNFα |
Tumor necrosis factor α |
TXNRD1,2,3 |
Thioredoxin reductase 1,2,3 |